World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. Then there is the cost of generic drugs. bil­lion in 2020 if it had pur­chased 77 of 89 drugs from Cuban’s firm.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

World of DTC Marketing

JULY 27, 2022

Pharma companies have very little control over patients’ prices for their Rxs. A drug’s out-of-pocket cost is primarily the result of decisions made by insurance companies and pharmacy benefit managers (PBMs). Insurers and PBMs have even devised schemes to overcharge patients for generic drugs.

Pharmacy 226

Pharmacy Generic Drugs Medicine Drugs 226

Pharmaceutical Technology

JULY 15, 2022

CivicaRx is a non-profit generic drug company producing affordable insulin biosimilars in collaboration with the Juvenile Diabetes Research Foundation (JDRF). Most of the US insulin market is controlled by three pharma companies: Sanofi, Eli Lilly, and Novo Nordisk. In-house manufacturing the norm.

Insulin 328

Insulin Manufacturing Contract Manufacturing Production 328

Drug Discovery World

AUGUST 8, 2023

According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2. To many, the country is referred to as the ‘pharmacy of the world’. So, what is driving this success, and will it continue?

Research 52

Research Drugs Genome Genomics 52